Balt offers a range of medical devices such as stents, coils, and catheters used to prevent and treat brain strokes and aneurysms. Headquartered in France, the company focuses on so-called ‘interventional neuroendovascular radiology’ (INR) devices, used in minimally invasive techniques to correct and stabilise strokes, aneurysms and arteriovenous malformations.
A pioneer in its field, the company operates within a niche market with a well-developed patented product portfolio and is accelerating its growth by adding further production capacity, focusing on product innovation and enlarging its distribution network worldwide. Volumes of INR devices are forecast to increase significantly as the number of patients diagnosed grows on the back of an ageing population and increased rates of obesity. 95% of the revenues are generated outside France.
